Regulations.gov document
‘‘Determining Whether To Submit an Abbreviated New Drug Application or a 505(b)(2)…
Notice · FDA-2017-D-5974 · posted Oct 13, 2017
Key facts
| Document ID | FDA-2017-D-5974-0001 |
|---|---|
| Title | ‘‘Determining Whether To Submit an Abbreviated New Drug Application or a 505(b)(2) Application;’’ Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5974 |
| Posted | Oct 13, 2017 |
| Federal Register citation | 82 FR 47749 |
| FR document number | 2017-22196 |
| Comment period opens | Oct 13, 2017 |
| Comments due | Dec 13, 2017 |
| Effective date | Oct 13, 2017 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: